Clinical trial NCT00860093 - References

Nephrolithiasis — Efficacy and Safety of Using MPC-5971 in Subjects Undergoing Shock Wave Lithotripsy

Citation(s)

•   Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A
  Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol. 1997 Dec;158(6):2069-73.
•   Gonzalez GB, Pak CY, Adams-Huet B, Taylor R, Bilhartz LE
  Effect of potassium-magnesium citrate on upper gastrointestinal mucosa. Aliment Pharmacol Ther. 1998 Jan;12(1):105-10.
•   Jaipakdee S, Prasongwatana V, Premgamone A, Reungjui S, Tosukhowong P, Tungsanga K, Suwantrai S, Noppawinyoowong C, Maskasame S, Sriboonlue P
  The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients. J Med Assoc Thai. 2004 Mar;87(3):255-63.
•   Koenig K, Padalino P, Alexandrides G, Pak CY
  Bioavailability of potassium and magnesium, and citraturic response from potassium-magnesium citrate. J Urol. 1991 Feb;145(2):330-4.
•   Odvina CV, Mason RP, Pak CY
  Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate. Am J Ther. 2006 Mar-Apr;13(2):101-8.
•   Pak CY, Koenig K, Khan R, Haynes S, Padalino P
  Physicochemical action of potassium-magnesium citrate in nephrolithiasis. J Bone Miner Res. 1992 Mar;7(3):281-5.
•   Ruml LA, Gonzalez G, Taylor R, Wuermser LA, Pak CY
  Effect of varying doses of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss. Am J Ther. 1999 Jan;6(1):45-50.
•   Ruml LA, Pak CY
  Effect of potassium magnesium citrate on thiazide-induced hypokalemia and magnesium loss. Am J Kidney Dis. 1999 Jul;34(1):107-13.
•   Ruml LA, Wuermser LA, Poindexter J, Pak CY
  The effect of varying molar ratios of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss. J Clin Pharmacol. 1998 Nov;38(11):1035-41.
•   Sriboonlue P, Jaipakdee S, Jirakulsomchok D, Mairiang E, Tosukhowong P, Prasongwatana V, Savok S
  Changes in erythrocyte contents of potassium, sodium and magnesium and Na, K-pump activity after the administration of potassium and magnesium salts. J Med Assoc Thai. 2004 Dec;87(12):1506-12.
•   Tosukhowong P, Tungsanga K, Phongudom S, Sriboonlue P
  Effects of potassium-magnesium citrate supplementation on cytosolic ATP citrate lyase and mitochondrial aconitase activity in leukocytes: a window on renal citrate metabolism. Int J Urol. 2005 Feb;12(2):140-4.
•   Wuermser LA, Reilly C, Poindexter JR, Sakhaee K, Pak CY
  Potassium-magnesium citrate versus potassium chloride in thiazide-induced hypokalemia. Kidney Int. 2000 Feb;57(2):607-12.
•   Zerwekh JE, Odvina CV, Wuermser LA, Pak CY
  Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest. J Urol. 2007 Jun;177(6):2179-84.

A Multi-Site Placebo-Controlled Randomized Double-Blind Study to Evaluate the Efficacy and Safety of Using MPC-5971 as Adjuvant Therapy in Subjects Undergoing Shock Wave Lithotripsy

Details for clinical trial NCT00860093